Pioglitazole and metformin hydrochloride 850 mg/1

Pioglitazone and metformin hydrochloride 850 mg/1 tablets combine two antidiabetic agents for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Pioglitazone and metformin hydrochloride 850 mg/1 tablets are commonly used to help manage type 2 diabetes. This combination therapy is designed to improve insulin sensitivity and reduce blood sugar levels. People often ask, 'What is pioglitazone and metformin used for?' The primary use is to support glycemic control in adults with type 2 diabetes, often alongside diet and exercise.

Common effects of pioglitazone and metformin hydrochloride 850 mg/1 tablets may include gastrointestinal discomfort, such as nausea or diarrhea. Some users also report weight gain or fluid retention. These effects can vary and are not experienced by everyone.

Handle pioglitazone and metformin hydrochloride 850 mg/1 tablets with care, especially if you have liver or kidney issues. Always follow the guidance of a healthcare provider regarding usage and monitor for any adverse reactions. Keep out of reach of children and store in a cool, dry place.

Pioglitazone and metformin hydrochloride 850 mg/1 tablets may interact with certain medications, including other diabetes drugs, insulin, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always consult a healthcare provider before combining with other treatments.